Low Serum Levels of High-density Lipoprotein Cholesterol and Hypolipidaemic Treatment

Low Serum Levels of High-density Lipoprotein Cholesterol and Hypolipidaemic Treatment

Summary Low serum levels of high-density lipoprotein (HDL) cholesterol is an independent risk factor for coronary artery disease. Raising HDL cholesterol should be an important therapeutic goal in patients with coronary artery disease. Fibrates can reduce the risk of cardiac events and death from co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current medical research and opinion 2002, Vol.18 (5), p.265-268
Hauptverfasser: Kolovou, Genovefa D., Cokkinos, Dennis V.
Format: Artikel
Sprache:eng
Schlagworte:
Antiatherogenic effects
Biological and medical sciences
Cardiovascular system
Cholesterol
Cholesterol, LDL - blood
Coronary artery disease
Coronary Disease - blood
Coronary Disease - prevention & control
Fibrates
Gemfibrozil - pharmacology
General and cellular metabolism. Vitamins
Humans
Hyperlipidemias - drug therapy
Hypolipidemic Agents - pharmacology
Hypolipidemic treatment
Low HDL-C
Medical sciences
Metabolism
Pharmacology. Drug treatments
Risk Factors
Statins
Vascular wall
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Low serum levels of high-density lipoprotein (HDL) cholesterol is an independent risk factor for coronary artery disease. Raising HDL cholesterol should be an important therapeutic goal in patients with coronary artery disease. Fibrates can reduce the risk of cardiac events and death from coronary artery disease.
ISSN:0300-7995
1473-4877
DOI:10.1185/030079902125000534